Diese Studien werden über einen Tweet bei Twitter gesammelt. Dort erweitert
sich die Liste ständig um neue Studien.
Ich danke allen, die diese Sammlung unterstützen!
Thread 1: https://twitter.com/AThobaben/status/1319934646549958656
Thread 2: https://twitter.com/AThobaben/status/1383142556343668737
Thread 3: https://twitter.com/AThobaben/status/1427653803248128006
1.
https://t.co/JLGccIFTip?amp=1
6-month consequences of COVID-19 in patients discharged from hospital
2.
https://t.co/sMssPxBLrj?amp=1
Association between mental illness and COVID-19 susceptibility
3.
https://t.co/zFVYzFnSWG?amp=1
Association of Psychiatric Disorders with Mortality among Patients with COVID-19
4.
https://t.co/OI6OzBL5Oc?amp=1
Bidirectional associations between COVID-19 and psychiatric disorder
5.
https://t.co/ktwxEhTlnn?amp=1
Broadly-targeted autoreactivity is common in severe SARS-CoV-2 Infection
6.
https://t.co/BpsTrybK2B?amp=1
Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection
7.
https://t.co/P4gwKAq28i?amp=1
Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact
8.
https://t.co/slzbnhM3A5?amp=1
Chronic COVID-19 Syndrome and Chronic Fatigue Syndrome (ME/CFS) following the first pandemic wave in Germany
9.
https://t.co/9BfPTs6cwz?amp=1
Cognitive deficits in people who have recovered from COVID-19
10.
https://t.co/Cq8sYVjhHX?amp=1
Comprehensive health assessment three months after recovery from acute COVID-19
11.
https://t.co/ZAtIujhY47?amp=1
Covid-19 Related Psychiatric Disorders
12.
https://t.co/i4GGd6kEzp?amp=1
COVID-19-related symptoms 6 months after the infection - Update on a prospective cohort study in Germany
13.
https://t.co/FQSlXsRBbR?amp=1
COVID-19-Spätfolge bei Kindern: Multisystemische Entzündung
14.
https://t.co/ONRklhEbut?amp=1
Evidence of thrombotic microangiopathy in children with SARS-CoV-2
15.
https://t.co/sc0FLqZtwh?amp=1
High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms
16.
https://t.co/UFzAwY2Z7U?amp=1
Living with COVID19 – A dynamic review of the evidence around ongoing Covid19 symptoms
17.
https://t.co/dI6cPOLvlV?amp=1
Long COVID in the Faroe Islands: A Longitudinal Study Among Nonhospitalized Patients
18.
https://t.co/VDJPD3Ir7A?amp=1
Mental Health and the Covid-19 Pandemic
19.
https://t.co/a0zZaJiH12?amp=1
Microvascular Injury in the Brains of Patients with Covid-19
20.
https://t.co/eJR6EoMVL9?amp=1
Multi-organ impairment in low-risk individuals with long COVID
21.
https://t.co/46Pbjm5l2y?amp=1
Neurobiology of COVID-19
22.
https://t.co/xva94v1uTh?amp=1
Neuroimaging manifestations in children with SARS-CoV-2 infection
23.
https://t.co/quhmbHBd76?amp=1
Neuroinvasion of SARS-CoV-2 in human and mouse brain
24.
https://t.co/DoMJpZr6bt?amp=1
Neuropsychiatric manifestations of COVID-19
25.
https://t.co/vYd6hXCdcX?amp=1
Persistent Brainstem Dysfunction in #LongCovid: A Hypothesis
26.
https://t.co/fVQ5z8IZpt?amp=1
Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection
27.
https://t.co/RBpQsPGsxd?amp=1
Persistent Symptoms in Patients After Acute COVID-19.
28.
https://t.co/dZlUtiA8Bh?amp=1
Physical phenotype of blood cells is altered in COVID-19
29.
https://t.co/t8lQysPLUq?amp=1
Posttraumatic Stress Disorder in Patients After Severe COVID-19 Infection
30.
https://t.co/G8Hn6LQaXO?amp=1
Preliminary Evidence on Long COVID in children
31.
https://t.co/W1S7t7maxb?amp=1
Psychiatric face of COVID-19
32.
https://t.co/CcnOdNX3KO?amp=1
Short-term Neuropsychiatric Outcomes and Quality of Life in COVID-19 Survivors
33.
https://t.co/aNyl2WgQKM?amp=1
The emerging spectrum of COVID-19 neurology
34.
https://t.co/VW4xvzpx9B?amp=1
The psychological typhoon eye effect during the COVID-19 outbreak in China: the role of coping efficacy and perceived threat
35.
https://t.co/mpvLAmCOAz?amp=1
Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections
36.
https://t.co/nZaSZHYd6C?amp=1
Longitudinal symptom dynamics of COVID-19 infection
37.
https://t.co/qnefVWaX5c?amp=1
Neuroinvasion of SARS-CoV-2 in human and mouse brain
38.
https://t.co/WCltzpOeq0?amp=1
Cognitive impact of COVID-19: looking beyond the short term
40.
https://t.co/CHP3gHERcG?amp=1
Clinical Characteristics, Activity Levels and Mental Health Problems in Children with Long COVID
41.
https://t.co/w5vTJRPp75?amp=1
Attributes and predictors of long COVID
42.
https://t.co/VIu3W2KwwW?amp=1
How COVID-19 Affects the Brain
43.
https://t.co/L6gcOBoeje?amp=1
Multisystem inflammatory syndrome in children
44.
https://t.co/uiFmBYd7jh?amp=1
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome
45.
https://t.co/yzU2NKUTFC?amp=1
Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers”
46.
https://t.co/M4Tsvd0men?amp=1
Physical, cognitive and mental health impacts of COVID-19 following hospitalisation
47.
https://t.co/SKRgMbNgjn?amp=1
Post-covid syndrome in individuals admitted to hospital with covid-19
48.
https://t.co/iyahsqwqq3?amp=1
6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19
49.
https://t.co/WdqYECUk6n?amp=1
Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK
50.
https://t.co/uiFmBYuIaP?amp=1
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome
51.
https://t.co/lyJFwVdaVV?amp=1
Chronic COVID-19 Syndrome and Chronic Fatigue Syndrome (ME/CFS) following the first pandemic wave in Germany
52.
https://t.co/WdqYECUk6n?amp=1
Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 1 April 2021
53.
https://t.co/SHEM6YiukY?amp=1
Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 4 June 2021
54.
https://t.co/jWD5fIBsYt?amp=1
Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study
55.
https://t.co/S1AtEiUsRF?amp=1
Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome
56.
https://t.co/ZT3Yt48wHV?amp=1
The Kids Are Not Alright: A Preliminary Report of Post-COVID Syndrome in University Students
57.
https://t.co/WHTIUopl31?amp=1
Long-COVID Syndrome? A Study on the Persistence of Neurological, Psychological and Physiological Symptoms
58.
https://t.co/GODgOghgKj?amp=1
Post-COVID syndrome in non-hospitalised patients with COVID-19
59.
https://t.co/gscUYPDblY?amp=1
Post-COVID Syndrome: Incidence, Clinical Spectrum, and Challenges for Primary Healthcare Professionals
60.
https://t.co/lxO0qarRr1?amp=1
Characteristics and predictors of acute and chronic post-COVID syndrome
61.
https://t.co/UZAN8hWqiN?amp=1
Clinical Characteristics, Activity Levels and Mental Health Problems in Children with Long COVID
62.
https://t.co/9yp9xBb2Uv?amp=1
Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19
63.
https://t.co/AXccPyrMn1?amp=1
Long COVID in a prospective cohort of home-isolated patients
64.
https://t.co/i3VYxCLRYo?amp=1
Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 1 July 2021
65.
https://t.co/K38TshPnA4?amp=1
Preparing for the long-haul: Autonomic complications of COVID-19
66.
https://t.co/mwyBKdZzJ2?amp=1
Long COVID and kids: scientists race to find answers
67.
https://t.co/Uv6Klvd6Ml?amp=1
Cognitive deficits in people who have recovered from COVID-19
68.
https://t.co/jySUR6xKOQ?amp=1
Children with SARS-CoV-2 in the National COVID Cohort Collaborative (N3C)
69.
https://t.co/uHd6cVr51D?amp=1
Long covid—mechanisms, risk factors, and management
70.
https://t.co/vZzJE1HQWW?amp=1
Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden
71.
https://t.co/5oGzrCnA00?amp=1
Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2
72.
https://t.co/dXe6MKW9Gt?amp=1
Retinal Microcirculation as a Correlate of a Systemic Capillary Impairment After Severe Acute Respiratory Syndrome Coronavi
rus 2 Infection |
73.
https://www.awmf.org/uploads/tx_szleitlinien/020-027l_S1_Post_COVID_Long_COVID_2021-07.pdf
S1-Leitlinie Post-COVID/Long-COVID (bei Kindern, Jugendlichen und Erwachsenen)
74.
https://www.awmf.org/uploads/tx_szleitlinien/020-027p_S1_Post_COVID_Long_COVID_2021-09_01.pdf
Patientenleitline "Long-/Post-COVID-Syndrom"
Dipl.-Psych. Amelie Thobaben und Dipl.-Psych. Henrike Kordy
Psychologische Psychotherapeutinnen
Friedrich-Ebert-Straße 124 | 28201 Bremen|
Amelie Thobaben:
0421 - 433 43 29 | info[at]praxis-thobaben.net (Therapieanfragen bitte in der telefonischen
Erreichbarkeit)
Henrike Kordy:
01520 - 6 33 64 70 | kordy[at]praxis-thobaben.net